Research into new way of－kmdeshaun的部落格

New methods of behaviour are appear to quarrel macular degeneration which is one of the ascendant causes of austere delirium loss in adults in the US and the mature planetary.

The new drugs contain Macugen from Pfizer/Eyetech, Retaane from Alcon, Kenalog and Lucentis. Macugen (Pegaptanib Sodium) is a new novel agent that targets the body?s harmful signals that end in out of the ordinary humor vessels to vegetate. This pills plant by targeting the supermolecule implicated in the organic process of atypical bodily fluid vessels. A surgeon injects this pills into the body fluid water in the eye after desensitising it. Macugen newmarket the establishment of new humour vessels and decreases leak from alive humour vessels. This psychotherapy is frequent both six weeks helps to forbid further loss of delusion.

Retaane (Anecortave Acetate) is a man-made steroid that targets negative processes that motive abnormal bodily fluid vessels to shoot in the eye and likewise blocks duple evil signals.

Piece:

Kenalog (Triamcinolone) is a steroid used to nutriment eye redness and swelling. Research is going on to learn whether injections of this tablets strength too develop nightmare for grouping stiff by macular devolution.

Another burgeoning drug is Lucentis (Ranibizumab). Lucentis as well complex by clogging malignancy of aberrant humor vessels in the eye. This agent shows swear an oath in not single preventing added imagination loss but as well in reversing the personalty of macular process. This linctus is soon in medical institution trials and is matter-of-course to be ready for prescription single by the preliminary quarter of 2007.

According to Age-Related Eye Disease Study (AREDS), a day-to-day addendum of 500 milligrams (mg) of sustenance C, 400 worldwide units (IU) of victuals E, 15 mg of beta carotene (often as vitamin A ? up to 25,000 IU), 80 mg of metallic element (as metallic element oxide), and 2 mg of copper (as cupric compound) can trim the hazard of forward to medium to stringent delirium loss by up to 25 proportion. For individuals with tone down to advanced macular degeneration, this scrutiny indicates that consumption of broad doses of zinc, of import carotene, and vitamins C and E is forceful in reduction the risk of more vision loss.

Research into new way of treating macular process is an in progress act and new advances support feat reported. It is sensible to ask a physician periodically to know whether new treatments have been introduced.